IQVIA

Senior Data Analyst – Oncology, Real World Solutions

Durham, North Carolina, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Candidates are required to possess a Master’s Degree in Biostatistics, Epidemiology, Data Science, or a related field, with a minimum of 5-8 years of relevant experience or a PhD with a minimum of 2 years of relevant experience. Prior programming experience using Flatiron Health data is essential, along with knowledge of statistics, programming, and real-world studies. Intermediate to advanced knowledge of SAS is preferred, with R acceptable.

Responsibilities

The Senior Data Analyst will lead the development of statistical programs and conduct analyses using oncology-specific secondary real-world data sources, including claims, EHR, HEOR, and genomic data. They will support the development of study documents such as statistical analysis plans and study reports, assess the feasibility of using real-world data sources, plan and program the integration of data from multiple sources, conduct analyses to characterize patient cohorts and QC datasets, manage and contribute to quality control of programs, communicate timelines and results to stakeholders, and provide technical expertise to project teams.

Skills

Statistical Programming
Oncology Data Analysis
Real-World Data (RWD)
Claims Data
EHR Data
HEOR Data
Genomic Data
Data Integration
Data Quality Control
Analysis Plan Development
Automation of Data Refreshes
Project Management
Communication Skills

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI